We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
10 hedge funds and large institutions have $23.6M invested in ESSA Pharma in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
1.9% more ownership
Funds ownership: 0% → 1.9% (+1.9%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
17% less funds holding
Funds holding: 12 → 10 (-2)
22% less capital invested
Capital invested by funds: $30.5M → $23.6M (-$6.83M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.25%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
–
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$40.5K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.35K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$914 |
Top Sellers
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$212K |
| 2 |
BC
Boxer Capital
San Diego,
California
|
-$74K |